TREA

90736220 - LINQURE

Follow

Information

  • Trademark
  • 90736220
  • Serial Number
    90736220
  • Registration Number
    7376828
  • Filing Date
    May 26, 2021
    3 years ago
  • Registration Date
    May 07, 2024
    8 months ago
  • Transaction Date
    May 07, 2024
    8 months ago
  • Status Date
    May 07, 2024
    8 months ago
  • Published for Opposition Date
    July 19, 2022
    2 years ago
  • Location Date
    May 06, 2024
    8 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    CHADAB, SETH WILLIG
  • Attorney Docket Number
    880685
    Attorney Name
    Julianne Abelman
  • Owners
Information
Mark Drawing Code
4
Mark Identification
LINQURE
Case File Statements
  • GS0051: Medicinal preparations for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases, namely, viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors; Viral systems, gene therapy systems, nucleic acid delivery systems for medical purposes, namely, medicines for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; clinical medical reagents for use in nucleic acid based therapy, gene therapy, cell therapy, gene diagnosis and gene testing
  • GS0441: Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics, namely, pharmaceutics in the field of gene therapy
  • GS0421: Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics, namely, pharmaceutics in the field of gene therapy
Case File Event Statements
  • 5/29/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 8/20/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/8/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/10/2022 - 2 years ago
    4 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 2/10/2022 - 2 years ago
    5 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 2/10/2022 - 2 years ago
    6 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 5/22/2022 - 2 years ago
    7 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 5/22/2022 - 2 years ago
    8 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 5/22/2022 - 2 years ago
    9 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 5/22/2022 - 2 years ago
    10 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 5/22/2022 - 2 years ago
    11 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 5/28/2022 - 2 years ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 5/31/2022 - 2 years ago
    13 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 5/31/2022 - 2 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/31/2022 - 2 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/13/2022 - 2 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/29/2022 - 2 years ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/19/2022 - 2 years ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/19/2022 - 2 years ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/20/2022 - 2 years ago
    20 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/20/2022 - 2 years ago
    21 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 7/20/2022 - 2 years ago
    22 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 7/20/2022 - 2 years ago
    23 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 8/18/2022 - 2 years ago
    24 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 1/12/2023 - 2 years ago
    25 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA
  • 1/25/2023 - a year ago
    26 - ASSIGNED TO PETITION STAFF Type: APET
  • 1/26/2023 - a year ago
    27 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP
  • 1/27/2023 - a year ago
    28 - CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED Type: CHPB
  • 5/7/2024 - 8 months ago
    29 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/7/2024 - 8 months ago
    30 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC